Matthew Griffor is Vice President at VestaBiotherapeutics, LLC specializing in recombinant protein design and production. He was employed at Pfizer, Inc in Groton, CT from 1997 to 2021, most recently as Associate Research Fellow where he supervised a lab that produced novel proteins for use in structural studies, vaccines, and protein therapeutics for the drug discovery process. His work on the structuralunderstanding of the SARS-CoV-2 spike protein interaction with the Ace2receptor helped drive the Covid-19 vaccine production. His recombinant GLP-1receptor work helped elucidate the specific protein interactions involved in asmall molecule oral GLP-1 receptor agonist that is in clinical trials. Currently,he oversees production of proprietary proteins for custom stem cell media atVesta Biotherapeutics, LLC.

‍